This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
9-Methyl-β-carboline
Polanski lab's 2007-2020 preclinical work (rat + primary cell culture) shows 9-Me-BC does an unusually long list of useful things to the…
Aliases (7)
Overview
What is 9-Methyl-β-carboline?
9-Methyl-beta-carboline (9-Me-BC) is a beta-carboline alkaloid, naturally trace-present in roasted coffee and certain plants. It is investigational and is used in the nootropic community for sustained dopaminergic and pro-cognitive effects without classical stimulant feel.
Key Benefits
Reported sustained cognitive enhancement, motivation, and dopaminergic tone; preclinical work shows neuroprotection of dopaminergic neurons and increased dendritic complexity. Anecdotally cumulative — effects build over days to weeks.
Mechanism of Action
Reversible MAO-A inhibitor, mild dopamine reuptake inhibitor, and inducer of neurotrophic factors (BDNF, GDNF). Shows neuroprotective action on dopaminergic neurons and increases dendritic arborization in preclinical models.
Pharmacokinetics
▸Brand options1 known
StatusUnscheduled in US; not FDA-approved for any indication; research-chemical-only — sold by research-chem vendors with "not for human consumption" labeling
Research Indications
What β-carbolines are (and why "9-methyl" matters)
β-carbolines are tricyclic pyridoindole alkaloids found endogenously in human brain and many plants (Banisteriopsis caapi / ayahuasca's h…
The five-arm mechanism (preclinical)
1. Tyrosine hydroxylase (TH) upregulation in dopaminergic neurons. TH is the rate-limiting enzyme in dopamine synthesis (tyrosine → L-DOP…
Pharmacokinetics — the empty box
Almost no human PK data exists. The Polanski-lab work is animal-only. From the limited animal + biohacker-inferred data: - Half-life: Est…
Peptide Interactions
Mechanistically complementary — bromantane upregulates TH via cAMP/PKC + CpG demethylation; 9-Me-BC upregulates TH via PI3K/Akt + transcription-factor (Gata2…
Both hippocampal neurogenesis-tropic, different molecular routes (NSI-189: BDNF + GDNF + VEGF + SCF; 9-Me-BC: BDNF + artemin + NT-3 via astrocyte recruitment…
Could plausibly combine — cerebrolysin delivers neurotrophic peptide fragments parenterally; 9-Me-BC induces endogenous neurotrophic factor expression. Diffe…
Apigenin is a MAO-A/B inhibitor in vitro at high doses; combination would likely be additive rather than synergistic. Avoid stacking at high doses of either.
MAO-overlap concern. Selegiline at 1-2.5 mg oral is MAO-B-selective (~90% selectivity); 9-Me-BC inhibits both MAO-A (preferentially) and MAO-B. Stacking adds…
Same logic — additive MAO inhibition. Avoid.
Theoretical serotonin-syndrome risk via MAO-A inhibition arm. Avoid.
Additive MAO inhibition + DNA-photosensitization risk. Avoid.
MAO-A inhibition will potentiate amphetamine-induced monoamine release — hypertensive risk. Modafinil is theoretically lower-risk (no monoamine-release mecha…
Theoretical risk of excessive peripheral catecholamine accumulation. Avoid.
Quality Indicators
Pharmacy-dispensed, intact packaging
Prescription tablets in original sealed packaging from a licensed pharmacy.
Generic vs branded
Generics are usually fine but bioavailability can vary slightly; track if you switch.
Unbranded blister or counterfeit risk
Counterfeit pharmaceuticals are a known issue; verify pharmacy and lot if buying internationally.
What to Expect
- Day 1PK-driven acute peak per administration. Verify dose tolerated.
- Week 1Steady-state reached for most daily-dosed pharma.
- Week 2-4Therapeutic effect established; titration window if needed.
- Long-termPeriodic monitoring per drug class (labs, BP, ECG as applicable).
Side Effects & Safety 8
Side Effects
- 1Headache (early dosing, often resolves)
- 2GI upset / nausea
- 3Sublingual taste loss (sublingual route only — persistent, can last 1-2 weeks)
- 4Photosensitivity (skin reaction on UV exposure — see watch period)
- 5Mild anxiety / edge (especially >15-20 mg)
- 6Dizziness, flushing
- 7Increased dream vividness (MAO-A inhibition extending monoamine half-life)
- 8Mood disturbance (reports of irritability or aggression at higher doses)
When to Stop
- UVA-induced DNA damage — Wenz et al. 2013 (RSC Org Biomol Chem, "Mechanisms of DNA damage by photoexcited 9-methyl-β-carbolines") demonstrated that 9-methyl-β-carbolines under UVA irradiation in cellular assays produce 8-oxo-7,8-dihydroguanine (a mutagenic oxidized purine), single-strand DNA breaks, abasic sites, micronucleus formation, and decreased cell proliferation. The DNA damage pattern is type-I photochemical (radical-mediated) and predominantly oxidized-purine-skewed. Translation to whole-organism cancer risk in chronic biohacker users is unquantified — the effect is documented in cell models, has not been studied in human skin in vivo, but the mechanism is concerning enough that "stay out of strong sun while dosing and for 3-7 days after stopping" is the consensus biohacker recommendation. For a combat athlete with outdoor training exposure, this is non-trivial.
- Tyramine pressor reaction (theoretical, MAO-A inhibition mechanism) — IC50 1 μM for MAO-A means at sufficient plasma concentration the molecule could behave like a partial MAO-A inhibitor. Tyramine-rich foods (aged cheese, fermented soy, tap beer, cured meat) could in principle produce hypertensive reactions. No documented human cases, but the mechanism warrants dietary awareness on chronic dosing.
- Serotonin syndrome (theoretical) — combining 9-Me-BC with serotonergic drugs (SSRIs, SNRIs, tramadol, MDMA, high-dose DXM, St. John's Wort) is theoretically dangerous. No documented human cases, but the MAO-A inhibition arm makes the textbook risk real.
- α-synuclein/dopaminergic effects in chronic high-dose use — the Parkinson's-relevant dimethyl-β-carboline congeners are dopaminergic neurotoxins. 9-methyl appears protective in the published literature, but very-long-term effects in humans are entirely uncharacterized.
- Hepatic effects (theoretical) — β-carboline class includes some hepatotoxic compounds; 9-Me-BC liver-toxicity profile in humans is uncharacterized. ALT/AST monitoring at 4-week intervals if cycling repeatedly is prudent.
- Photosensitivity: entire dosing period + 3-7 days post-discontinuation. Avoid prolonged direct UV exposure. SPF 50+ on uncovered skin if outdoor exposure unavoidable. This is the most concrete and most-commonly-violated safety guidance.
- First 2 weeks: monitor mood (anxiety/aggression flag), GI tolerance, photosensitivity reaction.
- Month 1+ chronic use: ALT/AST, BP, mood-self-report.
References
Wikipedia: 9-Methyl-β-carboline
chemistry, dosing range, mechanism summary, photosensitivity note
View StudyKeller et al. 2020, J Neural Transm (PMC8592951)
MAO IC50 values (MAO-A 1 μM, MAO-B 15.5 μM); BDNF + artemin + NT-3 + NCAM1 + TGF-β2 fold-changes in astrocytes; PI3K/Akt pathway dependence
View StudyPolanski et al. 2010, J Neurochem (PMID 20374418)
"The exceptional properties of 9-methyl-β-carboline" — dopaminergic neuron stimulation/protection/regeneration + anti-inflammatory mechanism review-primary
View StudyHamann/Wagner/Polanski 2008, Neurotoxicology (PMID 17913302)
foundational TH upregulation paper in primary mesencephalic culture; 33% TH+ neuron increase peak at 90 μM
View StudyGruss et al. 2012, J Neurochem (PMID 22380576)
rat hippocampal dopamine + dendritic + synaptic + spatial-learning behavioral effects
View StudyPolanski et al. 2011 (PMID 21651332)
anti-Parkinson framing paper with regeneration + protection mechanism
View StudyWenz et al. 2013, Org Biomol Chem (PMID 23842892)
UVA-photoexcited DNA damage mechanism; 8-oxo-dG, single-strand breaks, micronuclei
View StudyHolistic Nootropics: 9-methyl-carboline
biohacker community mechanism summary + photosensitivity warning
View StudyNootropicology: 9-Me-BC review
dosing protocol consensus (5-30 mg), cycling, side-effect community reports
View StudyWholistic Research: 9-Me-BC
dosing protocol (1-6 mg starter → 15-30 mg maintenance), 15-24 hour half-life estimate, vendor pricing
View StudyPredator Nutrition: 9-MBC review (Hydrapharm)
stimulant tolerance reset use case, 15-30 mg daily, 4-week cycling
View StudyLongecity 9-Me-BC regeneration thread, page 12
biohacker user reports: 5-45 mg dose range, mood + motivation + libido effects, sublingual taste loss, anxiety at higher doses
View StudyKimera Chems 9-Me-BC product page
vendor source, $62-67 for 1 g powder or 60×20 mg caps
View StudyModern Aminos 9-Me-BC
alternative vendor, 60×15 mg capsules, US-made claim
View StudyHydrapharm 9-MBC product page
branded product, 15 mg/cap × 60, intermittent inventory as of 2026
View StudyInteraction between MAO-B Inhibitors and SSRIs (PMC6019085)
context for MAO-A/B + SSRI serotonin syndrome risk framing
View StudyNoomind: 9-Me-BC
biohacker overview with safety framing including "strict sun avoidance"
View StudyHow was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.